ST
Sophie Thornton
Jazz Pharmaceuticals (Ireland), Pfizer (United Kingdom), Liverpool John Moores University, University of Liverpool, Seagen (United States)
0000-0001-7693-7279
Employment
-
Jazz Pharmaceuticals (Ireland) Regional Medical Director - External Scientific Parterships & Solid Tumours2025 - Present
-
Pfizer (United Kingdom) Senior Medical Advisor (Oncology)2024 - 2025
-
Seagen (United States) Secondment - Regional Tumour Lead (HNSCC)2022 - 2023
-
Seagen (United States) Senior Medical Science Liaison (Oncology)2021 - 2023
-
Pierre Fabre (United Kingdom) Medical Science Liaison (Oncology)2020 - 2021
-
University of Liverpool Molecular Researcher2013 - 2020
Education
-
Liverpool John Moores University Masters of Business Administration2023 - 2026
-
University of Liverpool PhD Translational Medicine (Molecular Oncology)2014 - 2018
-
Liverpool John Moores University BSc (hons) Forensic Science2006 - 2010
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- Uveal Melanoma: Molecular Prognostication Methods Save
- Uveal Melanoma: Molecular Pathology Save
- Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis Save
- Unpacking the genetic etiology of uveal melanoma Save
- Targeted Next-Generation Sequencing of 117 Routine Clinical Samples Provides Further Insights into the Molecular Landscape of Uveal Melanoma Save
- Parsimonious Models for Predicting Mortality from Choroidal Melanoma. Save
- Importance of Partial Losses of Chromosome 3 in Uveal Melanoma in the BAP1 Gene Region. Save
- Genetics of Uveal Melanoma Save
- Detection of Novel Mutations in TTC28 and SF3B1 using Targeted Next Generation Sequencing (NGS) Panels for Uveal Melanoma. Save
- Developing Next Generation Sequencing (NGS) Panels for Uveal Melanoma to Detect Copy Number and Single Nucleotide Variants; comparing PCR and Hybrid Capture Target Enrichment. Save